PARCHIM
InactiveDirectors
Directors
1 director, last change in 2026
Board 1
Paulus de Vogel
Current
Director · since 31-03-2026 · 6-year term from 2026 · listed in the 2025 annual accounts, filed on 16-07-2026
Statutory auditor 1
NV Callens Vandelanotte
Current
Statutory auditor · current term since 21-10-2025 · permanent representative: Mathias Roef · listed in the 2025 annual accounts, filed on 16-07-2026
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“als nieuwe bestuurders van de Vennootschap, voor een termijn van zes jaar tot aan de gewone algemene vergadering van aandeelhouders die de…”
deed of 05-06-2026Owners and capital
Shareholders
2 ownersChain of control
- MAGIS PHARMA
- PARCHIM
Owners 2
- MAGIS PHARMAparentEquity €1.9m Profit of €448,930 in 2024 (loss of €146,010 in 2023)100%
- Magis Pharma GroupparentEquity €530,028 Loss of €399,056 in 2025 (loss of €9.4m in 2024)100%
Capital transactions
Shareholders according to the deeds
Stated in the act
act of 08-09-2026 ↗
- één en dezelfde aandeelhouder all shares
Mandate history
10 people, 2 in office
- Board
- Day-to-day management
- Statutory auditor
- began earlier
| Name | Functions and periods |
|---|---|
| Paulus de Vogel |
|
| NV Callens Vandelanotte |
|
| DE VOGEL Paulus Bastianus |
|
| GREEN MONKEY |
|
| VAN DER HAMSVOORT JEROEN |
|
| DB Consortium |
|
| TJ Management |
|
| Vialma Invest |
|
| BD Strategy |
|
| BALANSA |
|